Home / Technology & Media / 3D Bioprinters Market By Technology (Syringe Based, Laser Based, Magnetic Levitation, Inkjet-Based, Valve-Based), Application (Tissue and Organ Generation, Pharmaceuticals, Prosthetics and Implants, Biosensors & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

3D Bioprinters Market By Technology (Syringe Based, Laser Based, Magnetic Levitation, Inkjet-Based, Valve-Based), Application (Tissue and Organ Generation, Pharmaceuticals, Prosthetics and Implants, Biosensors & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Published: Apr 2016 | Report Code: 57766-04-16

This report on global 3D bioprinters market studies various technologies used for specific applications in the field of healthcare. bioprinters helps to replicate human organs and long term goal is to create a whole organ with this technology. However, this technology is in its rudimentary stage and as the system in developing stage it is slowly being accepted in the mainstream medical field.

For the purpose of this study, the various technology segments studied include syringe based 3D bioprinters, laser based 3D bioprinters, magnetic levitation 3D bioprinters, inkjet based 3D bioprinters and valve-based 3D bioprinters. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

On terms of application type, the global 3D printers market is studied to understand the market maturity and distribution of the market shares. The application segment is further categorized into tissue and organ generation, pharmaceuticals, prosthetics and implants, biosensors and others (food and animal products & personal product testing). Market size and forecast for these segments during 2013 to 2022 and their compounded annual growth rates for the period 2016 to 2022 are provided in this report.

The geographic segmentation of the global 3D bioprinters market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global 3D Bioprinters Market Portaiture
2.2 Global 3D Bioprinters Market, by Technology, 2015 (USD Mn)
2.3 Relativity Analysis: Global 3D Bioprinters Market, by Application, 2015 & 2022 (USD Mn)
2.4 3D Bioprinters Market Share, by Geography, 2015 (Value %)

Chapter 3 3D Bioprinters Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 3D Bioprinters Technology: Future Trends and Applications
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Gap between patients waiting for organ transplant and available organ donors
3.3.1.2 Rising demand for cost-efficient technology in drug development processes
3.3.2 Challenges
3.3.2.1 3D Bioprinters of organs face restriction related to the raw materials applied for printing
3.3.3 Opportunities
3.3.3.1 Prosthetics and Orthopedic implants manufactured with 3D Bioprinters technology is in developed stage
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis: 3D Printer Applications in Healthcare, 2015 (Value %)

Chapter 4 Global 3D Bioprinters Market, by Technology
4.1 Preface
4.2 Syringe Based 3D Bioprinters
4.3 Laser Based 3D Bioprinters
4.4 Magnetic Levitation 3D Bioprinters
4.5 Inkjet-Based 3D Bioprinters
4.6 Valve-Based 3D Bioprinters

Chapter 5 Global 3D Bioprinters Market, by Application
5.1 Preface
5.2 Tissue and Organ Generation
5.1 Pharmaceuticals
5.2 Prosthetics and Implants
5.3 Biosensors
5.4 Others (Food and Animal Products Manufacturing and Personal Product Testing)

Chapter 6 Global 3D Bioprinters Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Rest of the World (RoW)

Chapter 7 Company Profiles
7.1 BioBots, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
7.1.4 News Coverage
7.2 TeVido BioDevices, LLC
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Portfolio
7.2.4 News Coverage
7.3 3D Dynamic Systems Ltd.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Portfolio
7.3.4 News Coverage
7.4 Rokit, Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Portfolio
7.4.4 News Coverage
7.5 Aspect Biosystems Ltd.
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Portfolio
7.5.4 News Coverage
7.6 Cyfuse Biomedical K.K.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product portfolio
7.6.4 News Coverage
7.7 Organovo Holdings, Inc.
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Portfolio
7.7.4 News Coverage
7.8 Stratasys Ltd.
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.9 3D Systems, Inc.
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Portfolio
7.9.4 News Coverage
7.10 Envision TEC
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Portfolio
7.10.4 News Coverage
7.11 Other Notable Market Players

List Of Figures

FIG. 1 Global 3D Bioprinters Market, by Technology, 2015 (USD Mn)
FIG. 2 Relativity Analysis: Global 3D Bioprinters Market, by Application, 2015 & 2022 (USD Mn)
FIG. 3 Global 3D Bioprinters Market Share, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition, Global 3D Bioprinters Market, 2015
FIG. 5 Market Share Analysis: 3D Printer Applications in Healthcare, 2015 (Value %)
FIG. 6 Global Syringe Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 7 Global Laser Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Magnetic Levitation 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Inkjet-Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Valve-Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global 3D Bioprinters Market in Tissue and Organ Generation Segment, 2013 – 2022 (USD Mn)
FIG. 12 Global 3D Bioprinters Market in Pharmaceuticals Segment, 2013 – 2022 (USD Mn)
FIG. 13 Global 3D Bioprinters Market in Prosthetics and Implants Segment, 2013 – 2022 (USD Mn)
FIG. 14 Global 3D Bioprinters Market in Biosensors Segment, 2013 – 2022 (USD Mn)
FIG. 15 Global 3D Bioprinters Market in Others Segment, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global 3D Bioprinters Market Revenue, by Technology, 2013 – 2022 (USD Mn)
TABLE 2 Global 3D Bioprinters Market Revenue, by Application, 2013 – 2022 (USD Mn)
TABLE 3 Global 3D Bioprinters Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia - Pacific 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Rest of the World 3D Biprinters Market Revenue, by Regions, 2013 – 2022 (USD Mn)

3D Bioprinters are considered as one of the major innovation for healthcare industry due to its multiple applications that is expected to bring cost-efficiency and high precision in the several processes carried out in healthcare industry. Based on the applications, the 3D bioprinters market is segmented into:

  • Tissue and Organ Generation
  • Pharmaceutical
  • Prosthetics and Implants
  • Biosensors
  • Others

3D Bioprinters Market


Pharmaceuticals is the major application of 3D printers because drug development field in today’s world is highly focusing on side effects, improving treatment outcomes and deserting the ‘one-size-fits-all’ approach to medication management. In 2015, the US FDA approved the world’s first 3D printed pill, ‘Spritam levetiracetam’ for treating epileptic seizures. Thus, in the near future printed human tissues or organs will also help to test a drug without using animals and will lead to cruelty-free approach.

The 3D bioprinters market comprises of various technologies such as syringe based 3D bioprinting, laser based 3D bioprinting, magnetic levitation 3D bioprinting, inkjet based 3D bioprinting and valve-based 3D bioprinting.

  3D Bioprinters Market 

Syringe-based, laser based, magnetic levitation, inkjet-based and valve based 3D bioprinting are the major 3D bioprinting techniques analyzed for the purpose of these study. Among these, syringe based 3D bioprinting is the largest segment and is anticipated to maintain its lead during the forecast period. Syringe-based 3D bioprinting has a promising future in the field of regenerative medicine, particularly in organ and tissue reconstruction, as studies depict that this technology has the ability to generate the intra-organ branched vascular tree. The wide range of related bioprinters available in the market along with their proven efficiency in delivering breakthrough outcomes in the promising field of organ and tissue regeneration supports the growth of this segment.

For the purpose of this study, the global 3D bioprinters market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

 

3D Bioprinters Market 

In the base year 2015, North America was observed as the largest market for 3D bioprinters. Large scale research and academic studies being conducted in U.S. for further exploring the fullest potential of 3D bioprinting majorly drive the North America 3D bioprinters market. A multitude of research initiatives in the field of regenerative medicine and academic studies on novel drug development and biotechnology are the prime characteristics of the market that demand the use of latest bioprinting techniques. On the other hand, Asia-Pacific is the fastest developing regional market for 3D bioprinters. Countries such as Japan, China and Singapore are observed to be the greatest trendsetters in the region. Burgeoning adoption of technological innovations, and larger investments in research and development activities are the major characteristics of Asia Pacific market. The rapid development of healthcare and biotechnology infrastructure, growing scope for research and development are the prime phenomena driving the 3D bioprinting market in Asia Pacific

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients